What is the NAMS stock price prediction for next 2 weeks?

According to our price prediction algorithm,NewAmsterdam Pharma Company N.V. (NAMS) price will be around $25.77 in the next 2 weeks. This means it will decrease by -13.685532484929674 from the last closing price. This prediction may vary from other time period filters for NAMS stock.

What can be the highest Possible price of NAMS stock in next 2 weeks?

Our forecast algorithm expects that in 2 weeks, NAMS can achieve the highest price of $27.34 which is -8.425753639554873 lower than last closing price. This prediction may vary from other time period filters for NAMS stock.

What can be the lowest Possible price of NAMS stock in next 2 weeks?

As per the forecast and algorithmic analysis, NAMS stock price can be as low as $24.12 which is -19.208454296474724 lower than the current price in the next 2 weeks. This prediction may vary from other time period filters for NAMS stock.

Will NAMS stock go high in the next 2 weeks?

No, our stock forecasting algorithm shows that NAMS stock will lose-13.685532484929674 in the next 2 weeks. This prediction may vary from other time period filters for NAMS stock.

What is NAMS stock last closing price?

Last closing price of NAMS stock was $29.86.

What is NAMS stock price prediction?

NAMS stock price prediction means predicting the future closing prices of NAMS stock based on its past data. Our forecasting algorithm uses various machine learning and deep learning techniques to forecast the future behavior of NAMS stock in a certain time period.

How we predict NAMS stock future prices?

If you are searching for NAMS stock forecast, analysis or price prediction, then you might be wondering what NewAmsterdam Pharma Company N.V. (NAMS) will do in the future. Our NAMS price predictions are based on various Machine Learning based algorithms with an aim to try and predict future price movements. This NAMS price prediction will likely answer most of your questions.

How frequent we update NAMS stock predictions?

We are updating the forecasts for the NAMS stock on daily basis.

Is using ML forecasting for NAMS stock a good way?

Yes. Stock Price Prediction is one of the most exciting applications of Machine Learning. By leveraging data from the past, it is possible to use forecasting models to make accurate predictions about future stock prices. This can be incredibly beneficial for investors and traders, as it gives them the ability to make more informed decisions about when to buy and sell. Investing in the stock market can be a risky endeavor, but leveraging Machine Learning can make it a bit less daunting and more profitable.

Is the Prediction for NAMS stock same for all the time periods?

No, the prediction for NAMS stock is not same for all time periods. The forecasts may vary depending on the differences in the time period.

NewAmsterdam Pharma Company N.V. Stock Forecast and Stock Price Prediction

Stock Forecast Chart

Stock Price Prediction Summary

Closed Price$29.86-8.07%Since 2 Weeks

Predicted Price$25.77-13.69%For 2 Weeks

Upper Predicted Price$27.34-8.43%For 2 Weeks

Lower Predicted Price$24.12-19.21%For 2 Weeks

Forecast Score Based on 2 Weeks

Based on our forecast, the price of NAMS will decline by -13.69% over the next 2 Weeks and hit $25.77 by Monday, May 18, 2026. In that time frame, NAMS's share price is expected to range between $24.12 and $27.34.

BearishAverageBullish

Date	Predicted Lower	Predicted	Predicted Upper
May 18, 2026	24.12	25.77	27.34
May 15, 2026	24.63	26.21	27.78
May 14, 2026	25.50	27.04	28.49
May 13, 2026	25.81	27.27	28.77
May 12, 2026	26.23	27.63	29.10
May 11, 2026	26.36	27.82	29.15
May 8, 2026	26.92	28.25	29.55
May 7, 2026	27.66	29.09	30.44
May 6, 2026	27.88	29.31	30.71
May 5, 2026	28.26	29.67	31.09

NAMS shares rose +5.03% in Monday, May 4, 2026's trading session, rising from a previous close of $28.43 to move at $29.86. The stock demonstrated notable intraday movement (see NAMS's key stats for a full breakdown), fluctuating between $28.09 and $29.90, a +6.44% trading range. While recent weeks have seen some volatility, NAMS has managed to secure a -13.90% drop over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 1.35M shares changing hands, 759.37K more than the previous session. This amounted to $40.40M in total market activity.

Will NAMS Continue Its Downward Trend?

According to analyst ratings and projections for NAMS, NewAmsterdam Pharma Company N.V. shares are anticipated to decrease by -9.20%, potentially reaching $27.34 per share by May 18, 2026. Short-term technical indicators currently suggest a neutral sentiment for NAMS. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 15 positive trading days within the past 30 sessions. Based on the NAMS stock forecast, now is not the best time to buy NAMS stock because its current trading price is +15.86% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on NAMS covering social and institutional perspectives.

NAMS Technical Momentum: Overbought, Oversold, or Neutral?

An analysis of Relative Strength Index (RSI) indicators provides insight into NAMS's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 42.96% to 44.60%) suggest the stock is in a neutral to slightly bearish momentum phase. The 50-day RSI, at 47.23%, suggests a neutral medium-term outlook. Additionally, the 100-day RSI, at 49.44%, maintains a neutral outlook for the long term. Insights into NAMS's shareholder base show how institutional investors are positioning themselves during these momentum shifts

NewAmsterdam Pharma NV Short-Term Forecasts

NAMS Forecast For Next 5 Days

Our algorithm anticipates NewAmsterdam Pharma NV (NAMS) stock could hit $29.95 by May 11, 2026. This represents a +0.31% fall from today's price, following a -0.86% change over the past five days.

NAMS Forecast For Next 30 Days

Based on analysis of market trends, the outlook for NewAmsterdam Pharma Company N.V. (NAMS) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $30.98, which would mean a +3.75% increase from the current price of $29.86. Projections for this period range from a high of $35.90 to a low of $25.69.

NAMS Forecast For Next 90 Days

Our proprietary market analysis suggests predictions for NewAmsterdam Pharma NV's price over the next three months point to a rise. NAMS stock is expected to peak at $35.34 on Aug 05, 2026 after potentially dipping to $28.01 on May 14, 2026. On average, NAMS is likely to trade around $31.58 in the coming 90 days.

NewAmsterdam Pharma NV Stock Forecast 2025

Based on our predictive models, NewAmsterdam Pharma NV (NAMS) is expected to trade between $28.01 and $43.35 throughout 2026. This would result in an average price of $33.25, potentially offering investors a +11.35% return from current levels.

NewAmsterdam Pharma Company N.V. Monthly Forecast 2026–2027

May 2026

According to our latest forecast models, NewAmsterdam Pharma Company N.V. (NAMS) is positioned to show a strong performance in May 2026. The price is predicted to move between $28.01 and $32.80, settling at an average of $30.21. This could translate to a +1.17% gain.

June 2026

Based on current market signals, NewAmsterdam Pharma Company N.V. is projected to trend june 2026. We forecast a trading range from $29.41 to $33.54, with a likely average price of $31.43. Investors could expect a potential return of +5.26%.

July 2026

Our predictive algorithms indicate NewAmsterdam Pharma Company N.V. stock may see a shift in July 2026. The expected range spans $30.13–$34.88, with an average target of $32.59. This represents a positive outlook and a possible gain of +9.14%.

August 2026

Analyzing established trends, NewAmsterdam Pharma Company N.V. looks set to move in August 2026. Projections place the stock between $31.53 and $36.24, averaging around $33.84. This suggests a +13.33% gain from current levels.

September 2026

Market indicators suggest NewAmsterdam Pharma Company N.V. could experience notable changes during September 2026. Prices could fluctuate within $31.08 to $35.87, with a midpoint forecast of $33.64. The stock might deliver a +12.66% gain.

October 2026

Forecasting for October 2026, models estimate that NewAmsterdam Pharma Company N.V. may undergo key fluctuations. If trends hold, the stock might trade between $31.03 and $36.15, averaging $33.35. This signals a positive trajectory with potential returns around +11.69%.

November 2026

According to our latest forecast models, NewAmsterdam Pharma Company N.V. (NAMS) is positioned to show a strong performance in November 2026. The price is predicted to move between $32.37 and $43.35, settling at an average of $34.76. This could translate to a +16.41% gain.

December 2026

Based on current market signals, NewAmsterdam Pharma Company N.V. is projected to trend december 2026. We forecast a trading range from $33.18 to $38.31, with a likely average price of $35.74. Investors could expect a potential return of +19.69%.

January 2027

Our predictive algorithms indicate NewAmsterdam Pharma Company N.V. stock may see a shift in January 2027. The expected range spans $34.66–$39.07, with an average target of $36.88. This represents a positive outlook and a possible gain of +23.51%.

February 2027

Analyzing established trends, NewAmsterdam Pharma Company N.V. looks set to move in February 2027. Projections place the stock between $34.09 and $39.22, averaging around $36.59. This suggests a +22.54% gain from current levels.

March 2027

Market indicators suggest NewAmsterdam Pharma Company N.V. could experience notable changes during March 2027. Prices could fluctuate within $33.98 to $39.26, with a midpoint forecast of $36.39. The stock might deliver a +21.87% gain.

April 2027

Forecasting for April 2027, models estimate that NewAmsterdam Pharma Company N.V. may undergo key fluctuations. If trends hold, the stock might trade between $35.46 and $39.74, averaging $37.44. This signals a positive trajectory with potential returns around +25.39%.

May 2027

According to our latest forecast models, NewAmsterdam Pharma Company N.V. (NAMS) is positioned to show a strong performance in May 2027. The price is predicted to move between $36.71 and $40.34, settling at an average of $38.42. This could translate to a +28.67% gain.

NAMS's history of dividends and stock splits also plays a role in long-term investor confidence.